Cargando…
Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
OBJECTIVE: Cystic fibrosis (CF) is a common autosomal recessive genetic disease caused by a mutation in the CF transmembrane conductance regulatory (CFTR) gene. This study attempted to identify the most common CFTR mutations and any correlations between certain mutations and the clinical presentatio...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663315/ https://www.ncbi.nlm.nih.gov/pubmed/23724185 |
_version_ | 1782270970529054720 |
---|---|
author | Farjadian, Shirin Moghtaderi, Mozhgan Kashef, Sara Alyasin, Soheila Najib, Khadijehsadat Saki, Forough |
author_facet | Farjadian, Shirin Moghtaderi, Mozhgan Kashef, Sara Alyasin, Soheila Najib, Khadijehsadat Saki, Forough |
author_sort | Farjadian, Shirin |
collection | PubMed |
description | OBJECTIVE: Cystic fibrosis (CF) is a common autosomal recessive genetic disease caused by a mutation in the CF transmembrane conductance regulatory (CFTR) gene. This study attempted to identify the most common CFTR mutations and any correlations between certain mutations and the clinical presentation of the disease in CF patients in southwestern Iran. METHODS: Twenty nine common CFTR gene mutations were examined in 45 CF patients. FINDINGS: Chronic cough, intestinal obstruction, dehydration, heat exhaustion and steatorrhea were the most common early clinical symptoms among our patients. The most common mutation was ΔF508, with an allele frequency of 21%. The homozygous ΔF508 mutation was observed in eight patients (18%), and three patients (7%) were ΔF508 carriers. The 2183AA > G mutation was observed in four patients, one of whom was also a ΔF508 carrier. The R1162X mutation was detected in two patients. The G542X, R334W and N1303K mutations were detected each in one patient, the first of whom was also a ΔF508 carrier. CONCLUSION: Out of 45 patients, 27 (60%) had none of the CFTR gene mutations we tested for. The most frequent mutations in southwestern Iranian patients with CF should be identified by sequencing the entire CFTR gene in order to optimize the design of a diagnostic kit for common regional mutations. |
format | Online Article Text |
id | pubmed-3663315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-36633152013-05-30 Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran Farjadian, Shirin Moghtaderi, Mozhgan Kashef, Sara Alyasin, Soheila Najib, Khadijehsadat Saki, Forough Iran J Pediatr Short Communication OBJECTIVE: Cystic fibrosis (CF) is a common autosomal recessive genetic disease caused by a mutation in the CF transmembrane conductance regulatory (CFTR) gene. This study attempted to identify the most common CFTR mutations and any correlations between certain mutations and the clinical presentation of the disease in CF patients in southwestern Iran. METHODS: Twenty nine common CFTR gene mutations were examined in 45 CF patients. FINDINGS: Chronic cough, intestinal obstruction, dehydration, heat exhaustion and steatorrhea were the most common early clinical symptoms among our patients. The most common mutation was ΔF508, with an allele frequency of 21%. The homozygous ΔF508 mutation was observed in eight patients (18%), and three patients (7%) were ΔF508 carriers. The 2183AA > G mutation was observed in four patients, one of whom was also a ΔF508 carrier. The R1162X mutation was detected in two patients. The G542X, R334W and N1303K mutations were detected each in one patient, the first of whom was also a ΔF508 carrier. CONCLUSION: Out of 45 patients, 27 (60%) had none of the CFTR gene mutations we tested for. The most frequent mutations in southwestern Iranian patients with CF should be identified by sequencing the entire CFTR gene in order to optimize the design of a diagnostic kit for common regional mutations. Tehran University of Medical Sciences 2013-04 /pmc/articles/PMC3663315/ /pubmed/23724185 Text en © 2013 Iranian Journal of Pediatrics & Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Short Communication Farjadian, Shirin Moghtaderi, Mozhgan Kashef, Sara Alyasin, Soheila Najib, Khadijehsadat Saki, Forough Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran |
title | Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran |
title_full | Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran |
title_fullStr | Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran |
title_full_unstemmed | Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran |
title_short | Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran |
title_sort | clinical and genetic features in patients with cystic fibrosis in southwestern iran |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663315/ https://www.ncbi.nlm.nih.gov/pubmed/23724185 |
work_keys_str_mv | AT farjadianshirin clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran AT moghtaderimozhgan clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran AT kashefsara clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran AT alyasinsoheila clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran AT najibkhadijehsadat clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran AT sakiforough clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran |